Form 8-K - Current report:
SEC Accession No. 0001493152-21-000337
Filing Date
2021-01-06
Accepted
2021-01-06 17:11:09
Documents
3
Period of Report
2020-12-30
Items
Item 3.01: Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing
Item 4.01: Changes in Registrant's Certifying Accountant
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 form8-k.htm 8-K 44755
2 ex16-1.htm EX-16.1 3560
3 ex99-1.htm EX-99.1 10891
  Complete submission text file 0001493152-21-000337.txt   60692
Mailing Address 4851 TAMIAMI TRAIL N, SUITE 200 NAPLES FL 34103
Business Address 4851 TAMIAMI TRAIL N, SUITE 200 NAPLES FL 34103 239-302-1707
Enveric Biosciences, Inc. (Filer) CIK: 0000890821 (see all company filings)

EIN.: 954484725 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-38286 | Film No.: 21511592
SIC: 3674 Semiconductors & Related Devices